Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00248300 · ClinicalTrials.gov registry record · Phase 4
A Peri-intubation Oral Intervention to Reduce Oral Flora and VAP
A Phase 4 study of Pneumonia, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 4
- Development phase
- 156
- Enrollment target
- 1
- Study location
NCT00248300: Completed Phase 4 study of Pneumonia, sponsored by Virginia Commonwealth University.
NCT00248300 is a Phase 4 study of Pneumonia that has completed, run by Virginia Commonwealth University. The registered enrollment target is 156 participants, below the 4,516-participant average among 47 other Pneumonia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00248300, a Phase 4 study of Pneumonia, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 156 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is determine if a single, early dose of chlorhexidine applied within 12 hours after endotracheal tube insertion will reduce the bacteria in the oral cavity and the incidence of pneumonia in trauma victims.
Conditions Studied
Interventions
- OTHER Chlorhexidine
Study Locations (1)
Virginia
- Virginia Commonwealth University School of Nursing - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2005-08 |
| Est. Completion | 2008-08 |
| Phase | Phase 4 |
What the finished NCT00248300 record still lists
NCT00248300 is an interventional study that assigns participants to a tested intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap, below the 4,516-participant average among 47 other Pneumonia trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Pneumonia appearing as the primary indexed condition, and to 1 intervention - of which Chlorhexidine is the first listed.
NCT00248300 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT00248300 about?
NCT00248300 is a clinical study titled "A Peri-intubation Oral Intervention to Reduce Oral Flora and VAP". The purpose of this study is determine if a single, early dose of chlorhexidine applied within 12 hours after endotracheal tube insertion will reduce the bacteria in the oral cavity and the incidence of pneumonia in trauma victims.
What is the current status of trial NCT00248300?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 156 participants. The study started on 2005-08. Estimated completion is 2008-08.
What conditions does trial NCT00248300 study?
This clinical trial studies the following conditions: Pneumonia.
What interventions are being tested in trial NCT00248300?
The interventions under investigation include: Chlorhexidine (OTHER).
Who is sponsoring clinical trial NCT00248300?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00248300 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pneumonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00248300's enrollment target sits among peer trials
156 25th of 47 higher than 23 of 47 other Pneumonia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pneumonia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Multicenter Infection Surveillance Study Following Open Heart Surgery
COMPLETED · Phase 4
-
The APS Phenotyping Study
RECRUITING
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
Extending Dental Care to Nursing Home Residents to Reduce Mouth Infections and Incidence of Pneumonia and Improve Diabetic Glucose Control
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03082755 · 156 participants · Phase 4
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- NCT04047628 · 156 participants · Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- NCT04166877 · 156 participants · Phase 4
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
- NCT04533464 · 156 participants · Phase 2
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia